BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Jack Allen

Baird · Equity Research Analyst

Analyst rating accuracy & track record

Jack Allen does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
ALLOAllogene Therapeutics Inc
Buy$9.00May 2025+83.1%Miss
INKTMink Therapeutics Inc
Buy$4.00Nov 2024+63.9%Hit
VORVor Biopharma Inc
Buy$14.00Nov 2024−7.3%Miss
TILInstil Bio Inc.
Buy$180.00Sep 2024−53.9%Miss
TILInstil Bio Inc.
Buy$180.00Sep 2024−48.5%Miss
MREOMereo BioPharma Group PLC ADR
Buy$8.00Jun 2024−29.9%Miss
TILInstil Bio Inc.
Buy$32.00May 2024+14.2%Hit
TILInstil Bio Inc.
Buy$54.00Jan 2024+76.1%Hit
TILInstil Bio Inc.
Buy$54.00Jan 2024+120.3%Hit
TILInstil Bio Inc.
Buy$14.00Nov 2022−75.3%Miss
TILInstil Bio Inc.
Buy$24.00Nov 2022−83.3%Miss
TILInstil Bio Inc.
Buy$31.00Sep 2022−97.4%Miss
CLLSCellectis SA
BuyMay 2022−58.6%
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30